Ancient Psychedelic Mescaline Surprises Scientists with Unexpected Brain Activity Patterns

The oldest known plant drug containing mescaline, a compound derived from the peyote cactus, has been analyzed in a groundbreaking brain scan study. Discovered in southwest Texas and dated back to around 3,700 BC, these dried cactus tops were found to still contain detectable levels of mescaline when chemically analyzed in the early 2000s. This makes them not only historically significant but also scientifically intriguing due to their enduring bioactive properties.

The recent study, published in *Neuroscience Bulletin*, marks a pioneering effort to understand how mescaline affects brain activity. Conducted by researchers at Northeastern University’s Center for Translational Neuroimaging, the experiment involved scanning 24 rats after administering them a single dose of mescaline. The findings revealed an unexpected pattern: instead of targeting areas typically associated with psychedelic experiences, such as the forebrain, mescaline primarily engaged the cerebellum.

The cerebellum is known for its role in motor coordination and balance but also plays a crucial part in sensory processing and prediction. Neuroscientist Anna Devor proposed that the cerebellum acts like a "Great Gate," filtering out predictable sensory information to prevent overwhelming the brain with unnecessary data. Under the influence of mescaline, however, this gate seems to malfunction, leading to increased connectivity between the cerebellum and other brain regions while reducing internal activity.

This shift in function was evident when the rats were subjected to a smell test after being administered mescaline. Normally, almond odor would trigger responses across numerous brain areas; under mescaline's influence, these responses were largely suppressed, suggesting an altered sensory processing mechanism. The study also noted that while olfactory, tactile, and auditory senses were blunted, visual perception remained relatively unchanged.

These results challenge long-held assumptions about how psychedelics interact with the brain and highlight the need for further research into mescaline's effects on human subjects. Despite being classified as a Schedule 1 substance since 1970, which has largely halted scientific exploration, this study opens new avenues for understanding both ancient practices involving peyote use and contemporary therapeutic applications of psychedelic compounds.

The implications of these findings extend beyond the realm of neuroscience to broader cultural and historical contexts, offering insights into how early human societies may have perceived and utilized mescaline-containing plants. As scientists continue to explore the mysteries surrounding this ancient drug, questions about its potential benefits in treating mental health disorders and enhancing cognitive functions remain at the forefront of research agendas.

This study underscores the importance of interdisciplinary approaches in understanding complex phenomena like psychedelic drugs and their impact on human cognition and perception.